According to a story from StartUp Health, the organization has recently partnered with Chiesi Farmaceutici, an Italy-based pharmaceutical company, in order to call for innovation and new advancements in the field…
According to a press release from the biopharmaceutical company Cerecor, Inc., the US Food and Drug Administration (FDA) recently agreed to accept the company's Investigational New Drug (IND) application for its…
According to a story from news-medical.net, a team of researchers have found that patients with inflammatory bowel disease display distinct changes to the makeup of bacteria that live in their…
According to a story from PR Newswire, the international drug developer Eli Lilly and Company recently announced the results of a Phase 3 clinical trial testing the company's drug LARTRUVO…
According to an article published by Washington University of Medicine in St. Louis, scientists appear to have succeeded in slowing axon destruction in mice through standard gene therapy. Though an…
A concerned Texas mom finally has answers about the cause of her son’s sensory-processing problems, thanks to a special collaboration among her patient-advocacy group and the lab of Scripps Research…
The Florey Institute of Neuroscience (FIN), one of the world’s largest and most respected brain research centers, recently announced trial results for the drug CuATSM, developed by FIN, the School…
David Radford, a 63-year-old resident of Oxford, UK, and a liver cancer survivor, said his surgeon attributes his successful liver transplant to the new normothermic perfusion machine. As reported recently…
According to a story from Medical Xpress, a recent study found that people who survived Hodgkin lymphoma during their childhood were at a greater risk of developing another type of…
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
